A detailed history of Comerica Bank transactions in Xencor Inc stock. As of the latest transaction made, Comerica Bank holds 18,308 shares of XNCR stock, worth $457,883. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,308
Previous 19,366 5.46%
Holding current value
$457,883
Previous $366,000 0.55%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.7 - $21.65 $16,610 - $22,905
-1,058 Reduced 5.46%
18,308 $368,000
Q2 2024

Aug 15, 2024

SELL
$18.21 - $24.5 $46,854 - $63,038
-2,573 Reduced 11.73%
19,366 $366,000
Q1 2024

May 15, 2024

SELL
$18.65 - $26.52 $51,026 - $72,558
-2,736 Reduced 11.09%
21,939 $485,000
Q4 2023

Feb 14, 2024

BUY
$16.53 - $21.42 $1,619 - $2,099
98 Added 0.4%
24,675 $523,000
Q3 2023

Nov 21, 2023

BUY
$20.08 - $25.39 $493,506 - $624,010
24,577 New
24,577 $495,000
Q4 2022

Jan 26, 2023

SELL
$24.79 - $30.86 $246,040 - $306,285
-9,925 Reduced 23.06%
33,118 $0
Q3 2022

Oct 28, 2022

SELL
$24.62 - $32.44 $121,992 - $160,740
-4,955 Reduced 10.32%
43,043 $1.19 Million
Q2 2022

Aug 02, 2022

SELL
$19.74 - $29.01 $19,167 - $28,168
-971 Reduced 1.98%
47,998 $1.47 Million
Q1 2022

Apr 27, 2022

BUY
$26.68 - $41.63 $18,409 - $28,724
690 Added 1.43%
48,969 $1.31 Million
Q4 2021

Feb 18, 2022

SELL
$33.67 - $43.44 $1.98 Million - $2.56 Million
-58,933 Reduced 54.97%
48,279 $1.94 Million
Q3 2021

Nov 22, 2021

BUY
$30.65 - $35.68 $1.62 Million - $1.89 Million
52,848 Added 97.21%
107,212 $3.5 Million
Q2 2021

Aug 26, 2021

SELL
$34.33 - $44.68 $138,075 - $179,702
-4,022 Reduced 6.89%
54,364 $1.88 Million
Q1 2021

Apr 28, 2021

SELL
$40.81 - $53.88 $75,008 - $99,031
-1,838 Reduced 3.05%
58,386 $2.51 Million
Q4 2020

Jan 28, 2021

BUY
$36.63 - $47.63 $16,593 - $21,576
453 Added 0.76%
60,224 $2.63 Million
Q3 2020

Oct 30, 2020

BUY
$30.09 - $43.02 $216,196 - $309,098
7,185 Added 13.66%
59,771 $2.32 Million
Q2 2020

Jul 31, 2020

BUY
$27.76 - $33.42 $128,695 - $154,935
4,636 Added 9.67%
52,586 $1.7 Million
Q1 2020

May 01, 2020

BUY
$20.69 - $37.79 $33,435 - $61,068
1,616 Added 3.49%
47,950 $1.43 Million
Q4 2019

Feb 07, 2020

BUY
$32.75 - $41.43 $11,528 - $14,583
352 Added 0.77%
46,334 $1.59 Million
Q3 2019

Oct 31, 2019

BUY
$33.73 - $46.27 $1.55 Million - $2.13 Million
45,982 New
45,982 $1.55 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.49B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.